Avanir Pharmaceuticals, Inc. (AVNR) was a big mover last session with its shares rising nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading way above the past one month’s volatile price range of $3.36 to $4.14.
This pharmaceutical company has witnessed no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s jump is encouraging though, so make sure to keep a close watch on this firm in the near future.
Avanir currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Better-ranked Med-Drug stocks worth considering include Lannett Company, Inc. (LCI), BioCryst Pharmaceuticals, Inc. (BCRX) and Cardiome Pharma Corp. (CRME). While LCI sports a Zacks Rank #1 (Strong Buy), BCRX and CRME bear a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment